View Profile

Dr. Mohammad Hajimolaali

None · University of Patras

https://researchid.co/mohammadhajimolaali
@none
289Google Scholar Citations
8Google Scholar h-index
6Google Scholar i10-index

Research Interests

Drug delivery system -Liposome- targeting- Quality control-

Biography

I obtained my Ph.D. in Pharmaceutics from the University of Patras, Greece, in 2025. I possess several years of extensive experience across diverse sectors of the pharmaceutical manufacturing industry, with particular expertise in quality control systems, liposomal drug delivery systems, and pharmaceutical formulation development. My doctoral research focused on the design and development of hyaluronic acid lipid-conjugate coated liposomes for targeted drug delivery to triple-negative breast cancer. The study involved comprehensive in vitro evaluation using established cellular models to assess targeting efficiency, cytotoxicity, and cellular uptake.

Education

I obtained my Ph.D. in Pharmaceutics from the University of Patras, Greece, in 2025.

Recent Google Scholar Publications

  1. Applications of immunochemotherapy based on smart nanocarriers in gastric cancer
    Micro Nano Bio Aspects 4 (4), e239510 , 2025, 2025
  2. Anti-diabetic, anti-inflammatory, antioxidant, anticancer, antimicrobial, and tissue engineering applications of genipin compound in micro-and nanoformulations: A mini-review
    Micro Nano Bio Aspects 3 (4), 13-18 , 2024, 2024 | Citations: 1.0
  3. Hyaluronic acid lipid-conjugate coated liposome for targeted delivery of drugs to triple negative breast cancer: in-vitro evaluation on cellular models
    University of Patras, Greece. (***PhD Thesis***) , 2024, 2024
  4. Review of recent preclinical and clinical research on ligand-targeted liposomes as delivery systems in triple negative breast cancer therapy
    Journal of Liposome Research 34 (4), 671-696 , 2024, 2024 | Citations: 28.0
  5. Antibacterial and antioxidant activity of catechin, gallic acid, and epigallocatechin-3-gallate: focus on nanoformulations
    Cellular, Molecular and Biomedical Reports 3 (2), 62-72 , 2023, 2023 | Citations: 38.0

Links